NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...
Mark Cuban has spent more than four years building something the healthcare industry is still figuring out how to respond to. What started as a mail-order pharmacy selling generic drugs at transparent ...
The Companies That Own Their Drugs The Pharma Industry Is Not One Business. It Is Several. Most people, when they think of a ...
During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting campaign has ...
Pfizer inking the last of three settlements to postpone copycats to its transthyretin amyloid cardiomyopathy (ATTR-CM) med ...
Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...
New active pharmaceutical ingredients facility in North Carolina to enable end‑to‑end manufacturing for all advanced ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...
After striking a Most Favored Nation deal with the White House in January, Johnson & Johnson will now offer Xarelto at 68% ...
Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first ...
Daily Mail on MSN
FDA finds 'significant violations' committed by maker of pain, ADHD and anxiety drugs
The manufacturer of products sold as Tylenol codeine, Adderall and Klonopin received a warning letter from the FDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results